In this study, the hub genes of NPC, such as PTGS2, and pathways such as IL-17 signaling, were identified through bioinformatics analysis, which may be potential new therapeutic targets for NPC. This evidence concerns the gene PTGS2 and nasopharyngeal carcinoma.